CC ENDOCRINOLOGIE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CC ENDOCRINOLOGIE
Largest movements
- Cash +€43,189
up €43,189 (+1,452%), from €2,975 to €46,165
mainly Net result for the year (+€43,178) and Tax, wage and social debts (+€11,989)
- Tangible fixed assets +€10,914
new in 2025: €10,914
of which Plant, machinery and equipment: +€7,059
- Receivables within one year +€1,531
up €1,531 (+25.0%), from €6,113 to €7,644
- Profit (loss) carried forward +€43,178
up €43,178 (+1,854%), from €2,329 to €45,508
- Tax, wage and social debts +€11,989
up €11,989 (+385%), from €3,117 to €15,106
- Other debts +€836
up €836 (+134%), from €623 to €1,459
- Gross operating margin +€51,233
up €51,233 (+1,148%), from €4,462 to €55,695
- Purchases and services -€12,059
no longer reported in 2025 (was €12,059)
- Taxes +€10,739
up €10,739 (+1,741%), from €617 to €11,356
- Depreciation -€635
down €635 (-42.3%), from €1,500 to €865
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,810 | €65,876 | +€56,066 | +572% |
| Fixed assets | 21/28 | - | €10,914 | +€10,914 | |
| Tangible fixed assets | 22/27 | - | €10,914 | +€10,914 | |
| Plant, machinery and equipment | 23 | - | €7,059 | +€7,059 | |
| Furniture and vehicles | 24 | - | €3,855 | +€3,855 | |
| Current assets | 29/58 | €9,810 | €54,962 | +€45,152 | +460% |
| Amounts receivable within one year | 40/41 | €6,113 | €7,644 | +€1,531 | +25.0% |
| Other amounts receivable | 41 | €6,113 | €7,644 | +€1,531 | +25.0% |
| Cash at bank and in hand | 54/58 | €2,975 | €46,165 | +€43,189 | +1,452% |
| Deferred charges and accrued income | 490/1 | €721 | €1,153 | +€432 | +60.0% |
| Total equity and liabilities | 10/49 | €9,810 | €65,876 | +€56,066 | +572% |
| Equity | 10/15 | €4,329 | €47,508 | +€43,178 | +997% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | - | €0 | = | |
| Profit (loss) carried forward | 14 | €2,329 | €45,508 | +€43,178 | +1,854% |
| Amounts payable | 17/49 | €5,480 | €18,368 | +€12,888 | +235% |
| Amounts payable within one year | 42/48 | €5,480 | €18,368 | +€12,888 | +235% |
| Trade debts | 44 | €1,741 | €1,804 | +€63 | +3.6% |
| Suppliers | 440/4 | €1,741 | €1,804 | +€63 | +3.6% |
| Taxes, remuneration and social security | 45 | €3,117 | €15,106 | +€11,989 | +385% |
| Taxes | 450/3 | €3,117 | €15,106 | +€11,989 | +385% |
| Other amounts payable | 47/48 | €623 | €1,459 | +€836 | +134% |
| Goods, raw materials, services and sundry goods | 60/61 | €12,059 | - | -€12,059 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,500 | €865 | -€635 | -42.3% |
| Other operating charges | 640/8 | €4 | €146 | +€142 | +3,957% |
| Gross operating margin | 9900 | €4,462 | €55,695 | +€51,233 | +1,148% |
| Operating profit (loss) | 9901 | €2,959 | €54,684 | +€51,725 | +1,748% |
| Financial charges | 65/66B | €13 | €150 | +€138 | +1,100% |
| Recurring financial charges | 65 | €13 | €150 | +€138 | +1,100% |
| Profit (loss) for the period before taxes | 9903 | €2,946 | €54,534 | +€51,588 | +1,751% |
| Income taxes | 67/77 | €617 | €11,356 | +€10,739 | +1,741% |
| Profit (loss) for the period | 9904 | €2,329 | €43,178 | +€40,849 | +1,754% |
| Profit (loss) for the period to be appropriated | 9905 | €2,329 | €43,178 | +€40,849 | +1,754% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.